Cargando…

Why asthma might surprisingly protect against poor outcomes in COVID-19

Asthma may protect against poor outcomes in COVID-19 due to several possible mechanisms, including altered viral entry receptor expression, inhaled corticosteroid use, chronic inflammation, reduced exposure due to shielding and/or mucus hypersecretion https://bit.ly/3eiXOPP

Detalles Bibliográficos
Autores principales:	Farne, Hugo, Singanayagam, Aran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651838/ https://www.ncbi.nlm.nih.gov/pubmed/33154034 http://dx.doi.org/10.1183/13993003.03045-2020

Ejemplares similares

Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients
por: Gao, Yi, et al.
Publicado: (2021)

COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
por: Hanon, Shane, et al.
Publicado: (2020)

The impact of asthma on mental health and wellbeing during COVID-19 lockdown
por: Higbee, Daniel H., et al.
Publicado: (2021)

Biologics may have a beneficial effect in asthma patients with COVID-19
por: Izquierdo, José L., et al.
Publicado: (2021)

Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore
por: Wee, Liang En, et al.
Publicado: (2021)

Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights
por: Wark, Peter A.B., et al.
Publicado: (2021)

Outcomes over the first two years of treatment with mepolizumab in severe asthma
por: Elsey, Lynn, et al.
Publicado: (2021)

Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?
por: Lutchman, Dhamend
Publicado: (2020)

Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort
por: Bal, Christina, et al.
Publicado: (2022)

Short-term outcomes of COVID-19 and risk factors for progression
por: Long, Li, et al.
Publicado: (2020)

Association between age and clinical characteristics and outcomes of COVID-19
por: Liu, Yang, et al.
Publicado: (2020)

Universal use of face masks for success against COVID-19: evidence and implications for prevention policies
por: Esposito, Susanna, et al.
Publicado: (2020)

Circadian rhythm of exhaled biomarkers in health and asthma
por: Wilkinson, Maxim, et al.
Publicado: (2019)

Patient-reported outcome measures after COVID-19: a prospective cohort study
por: Wong, Alyson W., et al.
Publicado: (2020)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
por: Ierodiakonou, Despo, et al.
Publicado: (2016)

Instability of sputum molecular phenotypes in U-BIOPRED severe asthma
por: Kermani, Nazanin Z., et al.
Publicado: (2021)

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase
por: Smadja, David M., et al.
Publicado: (2021)

Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19
por: Kotwica, Aleksandra, et al.
Publicado: (2021)

DNA methylation modules in airway smooth muscle are associated with asthma severity
por: Perry, Mark M., et al.
Publicado: (2018)

The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
por: Masoli, Matthew, et al.
Publicado: (2021)

Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma
por: Busse, William W., et al.
Publicado: (2021)

Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL(−1)
por: Rabe, Klaus F., et al.
Publicado: (2022)

Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort
por: Holz, Olaf, et al.
Publicado: (2021)

COVID-19 phenotypes: leading or misleading?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Response to COVID-19 phenotyping correspondence
por: Bos, Lieuwe D.J., et al.
Publicado: (2020)

Healthcare workers with COVID-19 in Mexico
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Current smoking is not associated with COVID-19
por: Rossato, Marco, et al.
Publicado: (2020)

COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia
por: Seren, Seda, et al.
Publicado: (2021)

Face masks, respiratory patients and COVID-19
por: Soriano, Joan B., et al.
Publicado: (2020)

The (in)significance of TB and COVID-19 co-infection
por: Khurana, Alkesh Kumar, et al.
Publicado: (2020)

Correlation and causality: a COVID-19 conundrum
por: Morice, Alyn H.
Publicado: (2020)

COVID-19 and smoking: is nicotine the hidden link?
por: Russo, Patrizia, et al.
Publicado: (2020)

Pulmonary embolism in patients with COVID-19 pneumonia
por: Bompard, Florian, et al.
Publicado: (2020)

Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020)

Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021)

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
por: Klok, Frederikus A., et al.
Publicado: (2020)

Increased focus on non-animal models for COVID-19 and non-COVID lung research
por: Gribaldo, Laura, et al.
Publicado: (2021)

Does bronchoscopy help the diagnosis in COVID-19 infection?
por: Ora, Josuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tistmgjj98ulmpr45iorlll5ei